Qingdao Vland Biotech INC. (SHA:603739)
China flag China · Delayed Price · Currency is CNY
12.93
-0.17 (-1.30%)
Sep 2, 2026, 2:09 PM CST

SHA:603739 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
96.4369.8162.6480.7169.84132.57
Depreciation & Amortization
116.05115.95110.9973.7965.7151.7
Other Amortization
2.092.281.210.490.950.2
Loss (Gain) From Sale of Assets
-0.12-0.470.6-00.35-0.05
Asset Writedown & Restructuring Costs
-10.180.030.553-1.98
Loss (Gain) From Sale of Investments
0.3-2.65-1.67-15.64-3.48-7.63
Provision & Write-off of Bad Debts
13.9511.683.9212.9811.877.82
Other Operating Activities
15.6624.6351.1641.529.9719.65
Change in Accounts Receivable
-74.19-47.54-40.88-36.65-110.01-91.03
Change in Inventory
7.2-43.9413.84-35.62-19.16-33.19
Change in Accounts Payable
-4.63-9.19-6.4633.1551.0310.24
Operating Cash Flow
160.12113.95195.41153.5995.3189.51
Operating Cash Flow Growth
4.42%-41.69%27.22%61.16%6.47%-48.26%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-67.02-80.01-104.72-215.64-342.02-493.58
Sale of Property, Plant & Equipment
0.250.262.080.930.110.11
Cash Acquisitions
-3.77-3.77-18.36-16.84-0.91-45.96
Divestitures
2.462.460.41-0.2--
Investment in Securities
-47.7-16.6165.43-75.81-103.12-75.43
Other Investing Activities
45.223.0912.7110.9117.778.13
Investing Cash Flow
-70.58-74.59-42.46-296.66-428.17-606.73

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-752.99842.68661.27489.55360
Total Debt Issued
723.01752.99842.68661.27489.55360
Long-Term Debt Repaid
--716.04-915.25-461.16-203.7-192.44
Total Debt Repaid
-685.91-716.04-915.25-461.16-203.7-192.44
Net Debt Issued (Repaid)
37.136.95-72.57200.11285.85167.56
Issuance of Common Stock
---7.764.74498.82
Common Dividends Paid
-41.68-43.01-55.23-39.77-52.77-37.79
Other Financing Activities
-40.75-31.4-13.67-11.74-10.1-48.03
Financing Cash Flow
-45.33-37.46-141.47156.36227.72580.56

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.18-0.180.130.731.07-1.47
Net Cash Flow
44.031.7111.6114.03-104.0761.87

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
93.133.9490.69-62.05-246.72-404.06
Free Cash Flow Growth
34.65%-62.58%----
Free Cash Flow Margin
6.54%2.48%6.87%-5.18%-21.21%-35.11%
Free Cash Flow Per Share
0.360.140.36-0.25-0.95-1.65
Levered Free Cash Flow
34.15-29.1610.1420.05-241.42-418.19
Unlevered Free Cash Flow
39.17-17.9123.8229.56-236.94-416.86

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
104.51105.1983.8480.8244.6258.15
Change in Working Capital
-74.06-107.32-33.99-43.24-79.9-116.74